Cite
HARVARD Citation
Zhao, S. et al. (2019). Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma. Neuro-oncology. 21 (9), pp. 1141-1149. [Online].